ORIGINAL RESEARCH
Published on 03 Jul 2026
Comparative discriminative ability of CVAI and traditional insulin resistance indices for MAFLD in Chinese adults with type 2 diabetes
doi 10.3389/fendo.2026.1839268
- 899 views
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Metabolic Dysfunction-Associated Steatohepatitis (MASH): Intersections with Type 2 Diabetes and Insulin Resistance
Metabolic Dysfunction-Associated Steatohepatitis (MASH): Intersections with Type 2 Diabetes and Insulin Resistance
2,111
Total downloads
17k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 12 Jun 2026
Mortality trends in diabetes with proxy-defined steatotic liver disease in the United States, 1999–2023
doi 10.3389/fendo.2026.1828354
- 957 views
ORIGINAL RESEARCH
Published on 03 Jun 2026
Heterogeneity in risk and potential pathogenic associations of NAFLD among distinct prediabetic phenotypes in young and middle-aged adults
doi 10.3389/fendo.2026.1819674
- 1,505 views
ORIGINAL RESEARCH
Published on 12 May 2026
Identification of candidate biomarkers for NAFLD through bioinformatics analysis and machine learning based on circulating insulin degradation-associated genes
doi 10.3389/fendo.2026.1774997
- 1,258 views
ORIGINAL RESEARCH
Published on 01 May 2026
TyG-WHtR predicts incident type 2 diabetes mellitus in NAFLD: a 12-year prospective cohort study
doi 10.3389/fendo.2026.1805902
- 1,680 views
- 1 citation
ORIGINAL RESEARCH
Published on 02 Apr 2026
Associations of four insulin resistance indicators with subsequent pregnancy outcomes in women with recurrent pregnancy loss
doi 10.3389/fendo.2026.1767301
- 2,008 views
ORIGINAL RESEARCH
Published on 19 Mar 2026
Disentangling metabolic impairment in the liver-heart axis: tissue-specific insulin sensitivity in type 2 diabetes
doi 10.3389/fendo.2026.1786303
- 1,735 views
ORIGINAL RESEARCH
Published on 12 Feb 2026
A pilot study on a combined non-invasive screening test for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes
doi 10.3389/fendo.2026.1780005
- 882 views
REVIEW
Published on 19 Jan 2026
Synergistic therapeutic strategies for metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus: molecular insights and clinical advances
doi 10.3389/fendo.2025.1753393
- 3,004 views
- 1 citation
ORIGINAL RESEARCH
Accepted on 03 Aug 2026
Body composition assessment improves for risk stratification of hepatic steatosis in patients with type 2 diabetes and MASLD undergoing osteoporosis screening
SYSTEMATIC REVIEW
Accepted on 03 Aug 2026
Metabolic Dysfunction-Associated Steatohepatitis (MASH): Intersections with Type 2 Diabetes and Insulin Resistance
- 295 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.